A novel prostate cancer immunotherapy using prostate-specific antigen peptides and skin test reagent as an adjuvant

A novel prostate cancer immunotherapy using prostate-specific antigen peptides and skin test reagent as an adjuvant

Objectives: Our group developed the use of the Candida skin test reagent as an adjuvant of cell-mediated immunity in designing a human papillomavirus therapeutic vaccine. Here, this technology is being applied for designing a prostate cancer immunotherapy. Methods: Peptides based on the prostate-spe...

Full description

Bibliographic Details
Main Authors: Al-Ola Abdallah, Hannah Coleman, Mohamed Kamel, Rodney Davis, Teri Landrum, Horace Spencer, Sam Mackintosh, Fade A Mahmoud, Natasa Milojkovic, Chester Wicker, Konstantinos Arnaoutakis, Mayumi Nakagawa
Format: Article
Language:English
Published: SAGE Publishing 2018-09-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/2050312118800202

Internet

https://doi.org/10.1177/2050312118800202

Similar Items